Nadine Jagerovic

Madrid, MD 28006, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

PM289, a synthetic CB2 in vitro receptor agonist, modulates morphine-induced antinociceptive effect and withdrawal syndrome in an animal model of osteoarthritic pain.

PM289, a synthetic CB2 in vitro receptor agonist, modulates morphine-induced antinociceptive effect and withdrawal syndrome in an animal model of osteoarthritic pain.

Journal: Neuropharmacology

Published: January 13, 2026

Homodimerization of CB2 cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling.

Homodimerization of CB2 cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling.

Journal: Pharmacological research

Published: May 11, 2024

Progress on the development of Class A GPCR-biased ligands.

Progress on the development of Class A GPCR-biased ligands.

Journal: British journal of pharmacology

Published: December 11, 2023

Administration of Linoleoylethanolamide Reduced Weight Gain, Dyslipidemia, and Inflammation Associated with High-Fat-Diet-Induced Obesity.

Administration of Linoleoylethanolamide Reduced Weight Gain, Dyslipidemia, and Inflammation Associated with High-Fat-Diet-Induced Obesity.

Journal: Nutrients

Published: August 26, 2023

Activation of CB2R by synthetic CB2R agonist, PM289, improves brain endothelial barrier properties, decreases inflammatory response and enhances endothelial repair.

Activation of CB2R by synthetic CB2R agonist, PM289, improves brain endothelial barrier properties, decreases inflammatory response and enhances endothelial repair.

Journal: NeuroImmune pharmacology and therapeutics

Published: July 28, 2023

Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity Relationship.

Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity Relationship.

Journal: ACS medicinal chemistry letters

Published: July 14, 2022

The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB2 Receptors.

The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB2 Receptors.

Journal: Frontiers in pharmacology

Published: January 11, 2022

Targeting CB2 and TRPV1: Computational Approaches for the Identification of Dual Modulators.

Targeting CB2 and TRPV1: Computational Approaches for the Identification of Dual Modulators.

Journal: Frontiers in molecular biosciences

Published: December 22, 2021

Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis.

Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis.

Journal: Molecules (Basel, Switzerland)

Published: November 13, 2021

Palmitoleoylethanolamide Is an Efficient Anti-Obesity Endogenous Compound: Comparison with Oleylethanolamide in Diet-Induced Obesity.

Palmitoleoylethanolamide Is an Efficient Anti-Obesity Endogenous Compound: Comparison with Oleylethanolamide in Diet-Induced Obesity.

Journal: Nutrients

Published: May 26, 2021

Synthetic and Natural Derivatives of Cannabidiol.

Synthetic and Natural Derivatives of Cannabidiol.

Journal: Advances in experimental medicine and biology

Published: February 04, 2021

Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System.

Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System.

Journal: International journal of molecular sciences

Published: November 30, 2020

Showing 1-12 of 45

Last Updated: 09/26/2026